NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $518 | +41.5% | 5,090 | +40.5% | 0.04% | +50.0% |
| Q2 2023 | $366 | +9.9% | 3,623 | 0.0% | 0.03% | +3.7% |
| Q1 2023 | $333 | 0.0% | 3,623 | -1.4% | 0.03% | -3.6% |
| Q4 2022 | $333 | -99.9% | 3,675 | +14.0% | 0.03% | +21.7% |
| Q3 2022 | $245,000 | -14.9% | 3,225 | -5.3% | 0.02% | -8.0% |
| Q2 2022 | $288,000 | -3.7% | 3,405 | 0.0% | 0.02% | +8.7% |
| Q1 2022 | $299,000 | -18.8% | 3,405 | -19.0% | 0.02% | -20.7% |
| Q4 2021 | $368,000 | -34.4% | 4,204 | -38.7% | 0.03% | -38.3% |
| Q3 2021 | $561,000 | +1.8% | 6,854 | +13.5% | 0.05% | +2.2% |
| Q2 2021 | $551,000 | +1.3% | 6,041 | -5.0% | 0.05% | +2.2% |
| Q1 2021 | $544,000 | +149.5% | 6,359 | +187.1% | 0.04% | -6.2% |
| Q1 2015 | $218,000 | +6.3% | 2,215 | 0.0% | 0.05% | +4.3% |
| Q4 2014 | $205,000 | +2.5% | 2,215 | +4.0% | 0.05% | 0.0% |
| Q3 2014 | $200,000 | 0.0% | 2,130 | -3.6% | 0.05% | 0.0% |
| Q2 2014 | $200,000 | – | 2,210 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |